SPEAKERS Andres Hernandez de la Peña Principal Scientist Neomorph Andrew Potterton Head of Technology Platform Ternary Therapeutics Bin Liu Chief Executive Officer HB Therapeutics, Inc. Bradlee Heckmann Co-founder & Chief Scientific Officer ASHA therapeutics Dmitri Ivanov Associate Professor Biochemistry & Structural Biology University of Texas Health San Antonio Dong Seok Kim Chief Executive Officer AevisBio Inc. Fan Liu Co-Founder & Chief Technology Officer NeoX Biotech Inc. Felix Hausch Professor Technical University of Darmstadt Feng Wang Lab head Pfizer Jacob Hale Senior Scientist Novartis Jia Liu Principal Scientist PhoreMost Julia Dou Director of Protein Chemistry Degron Therapeutics Markus Queisser Scientific Director GlaxoSmithKline Plc Matthew Hayward Vice President of Drug Discovery Magnet Biomedicine Matthias Brand Chief Technology Officer Proxygen GmbH Meizhong Jin Senior Director – Oncology Chemistry AstraZeneca Peggy Thompson Vice President & Head of Biology Plexium Inc. Rana Quraishi Chief Executive Officer Isoprene Pharmaceuticals Rick Ewing Vice President & Head of Chemistry Rapafusyn Pharmaceuticals Stephane Gesta Vice President - Discovery & Translational Biology BPGBio Inc. Tauseef Butt President & Chief Executive Officer Progenra Yao Wang Chief Medical Officer - Immunology, Hematology, & Oncology Kangpu Biopharmaceuticals FULL EVENT GUIDE REGISTER PARTNER